Pfizer (PFE) Stock: Buy, Sell, or Hold?
$29.35
-0.02 (-0.05%)
▼
5d:
-4.69%
30d:
+3.44%
90d:
+9.5%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Feb 02, 2027
Protect PFE Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (71%)
Quality Score
56/100
Position
FAIR
30-Day Fair Range
$28.44 – $30.27
Position: FAIR
Forward P/E & Valuation
10.0x
FAIR
vs 9.3x historical avg
Wall Street Target
$30.26
+3.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$28.54 / $31.44
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: PFE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 3, 2026 at $30.00 · last confirmed Nov 10, 2026
Strength: 6.0/10
Get Alerted When PFE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.61
Based on 0.3% avg growth
INTRINSIC VALUE TODAY
$17.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PFE is currently trading at $29.34, which is considered fair relative to its 30-day fair value range of $28.44 to $30.27. The stock's valuation (Forward PE: 10.0) is in line with its historical norms (9.3). At these levels, the market is pricing in 2.6% annual earnings growth.
Technical Outlook: Technically, PFE is in a strong uptrend. The price is currently testing key support at $28.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PFE is in a strong uptrend. The price is currently testing key support at $28.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$28.44 -
$30.27
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
Trading Range & Key Levels
30-Day Trading Range
$28.44 -
$30.27
Current vs Trading Range
FAIR
Support Level
$28.54
Resistance Level
$31.44
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding PFE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($30.26)
- BULLISH: Expecting earnings turnaround to 2.6% growth with -0.4% revenue growth
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
10.00
Wall Street Target
$30.26
(+3.1%)
Revenue Growth (YoY)
-0.4%
Earnings Growth (YoY)
-9.7%
Profit Margin
6.3%
Valuation Premium vs History
+2.6% premium
PE vs Historical
10.0 vs 9.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$30.12
(+3%)
2-Year Target
$30.91
(+5%)
3-Year Target
$31.71
(+8%)
3-Yr Target (if PE normalizes)
(PE: 10→9)
PE COMPRESSION
$29.50
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -3.5%)
$52.39
(+78%)
Base:
(SPY PE: 10.0, Growth: -3.5%)
$26.37
(-10%)
Bear:
(PE: 8.5, Growth: -3.5%)
$22.41
(-24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 41.76 | Current EPS (TTM): $0.70
Bull Case
$64.31
(+119%)
Analyst growth 100.0%, PE expands to 45.9
Base Case
$58.46
(+99%)
Market implied 100.0%, PE stable at 41.8
Bear Case
$19.88
(-32%)
Severe decline -20.0%, PE contracts to 35.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share PFE Analysis
Share this live PFE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PFE)
Bullish
5 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages express bullish sentiment towards $PFE, with traders focusing on its current price position near bollinger bands and moving averages. A Yahoo Finance article discusses three dividend stocks, including Pfizer, as potential safe options during market volatility.
Key Retail Themes:
StockTwits traders' focus on $PFE's price position
The Yahoo Finance article's discussion of dividend stocks as safe options during market volatility
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:49 PM ET
Data refreshes hourly during market hours. Next update: 2:49 PM
Data refreshes hourly during market hours. Next update: 2:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
PFE is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 48 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 43 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 27 SELL |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 50 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 37 SELL |
Advanced PFE Option Strategies
Professional options setups generated by AI based on today's PFE price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PFE Research Pages
